Overview: Issues in Young Children and Adults

  • Teiji Tominaga
  • Miki Fujimura


Moyamoya disease is a chronic, occlusive cerebrovascular disease with unknown etiology which has two peaks in age distribution, a first peak in children and the second peak in young adults [1]. The most recent epidemiological national survey in Japan estimates that the annual number of the patients with moyamoya disease is 7,700 with the incidence rate of 5.4 per million populations, with the female/male ratio of 1.8:1 [2]. The peaks in age distribution of moyamoya disease consist of a first peak in children and the second peak in young adults. The incidence of patients with family history was 12.1% among definitive moyamoya patients [2]. In this chapter, the authors seek to overview the characteristics of moyamoya disease in children and young adults.


Transient Ischemic Attack Moyamoya Disease Revascularization Surgery Intensive Blood Pressure Cerebral Hyperperfusion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Suzuki J, Takaku A (1969) Cerebrovascular ‘moyamoya’ disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 20:288–299Google Scholar
  2. 2.
    Kuriyama S, Kusaka Y, Fujimura M, et al. (2008) Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey. Stroke 39:42–47PubMedCrossRefGoogle Scholar
  3. 3.
    Ikeda H, Sasaki T, Yoshimoto T, et al. (1999) Mapping of a familial moyamoya disease gene to chromosome 3q24-p26. Am J Hum Genet 64:533–537PubMedCrossRefGoogle Scholar
  4. 4.
    Sakurai K, Horiuchi Y, Ikeda H, et al. (2004) A novel susceptibility locus for moyamoya disease on chromosome 8q23. J Hum Genet 49:278–281PubMedCrossRefGoogle Scholar
  5. 5.
    Yamaguchi T, Tada M, Houkin K, et al. (2000) Linkage of familial moyamoya disease to chromosome 17q25. Stroke 31:930–935CrossRefGoogle Scholar
  6. 6.
    Mineharu Y, Liu W, Inoue K, et al. (2008) Autosomal dominant moyamoya disease maps to chromosome 17q25.3. Neurology 70:2357–2363PubMedCrossRefGoogle Scholar
  7. 7.
    Oka K, Yamashita M, Sadoshima S, et al. (1981) Cerebral hemorrhage in moyamoya disease at autopsy. Virchows Arch Pathol Anat Histol 392:247–261CrossRefGoogle Scholar
  8. 8.
    Oki K, Suzuki N (2007) In: Hashimoto N (ed) Report by the Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease), pp 4–5Google Scholar
  9. 9.
    Yoshida Y, Yoshimoto T, Shirane R, et al. (1999) Clinical course, surgical management, and long-term outcome of moyamoya patients with rebleeding after an episode of intracerebral hemorrhage: a extensive follow-up study. Stroke 30:2272–2276PubMedCrossRefGoogle Scholar
  10. 10.
    Kuroda S, Hashimoto N, Yoshimoto T, et al. (2007) Radiological findings, clinical course, and outcome in asymptomatic moyamoya disease. Results of multi-center survey in Japan. Stroke 38:1430–1435Google Scholar
  11. 11.
    Fukui M (1997) Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis (‘moyamoya disease’). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg 99 Suppl 2:S238–240PubMedGoogle Scholar
  12. 12.
    Kuroda S, Ishikawa T, Houkin K, et al. (2005) Incidence and clinical features of disease progression in adult moyamoya disease. Stroke 36:2148–2153PubMedCrossRefGoogle Scholar
  13. 13.
    Ikezaki K, Matsushima T, Kuwabara Y, et al. (1994) Cerebral circulation and oxygen metabolism in childhood moyamoya disease: a perioperative positron emission tomography study. J Neurosurg 81:843–850PubMedCrossRefGoogle Scholar
  14. 14.
    Saito N, Nakagawara J, Nakamura H, et al. (2004) Assessment of cerebral hemodynamics in childhood moyamoya disease using a quantitative and a semiquantitative IMP-SPECT study. Ann Nucl Med 18:323–331PubMedCrossRefGoogle Scholar
  15. 15.
    Ishikawa T, Houkin K, Kamiyama H, et al. (1997) Effects of surgical revascularization on outcome of patients with pediatric moyamoya disease. Stroke 28:1170–1173PubMedCrossRefGoogle Scholar
  16. 16.
    Scott RM, Smith JL, Robertson RL, et al. (2004) Long-term outcome in children with moyamoya disease after cranial revascularization by pial synangiosis. J Neurosurg 100:142–149PubMedGoogle Scholar
  17. 17.
    Morimoto M, Iwama T, Hashimoto N, et al. (1999) Efficacy of direct revascularization in adult moyamoya disease: haemodynamic evaluation by positron emission tomography. Acta Neurochir (Wien) 141:377–384CrossRefGoogle Scholar
  18. 18.
    Mizoi K, Kayama T, Yoshimoto T, et al. (1996) Indirect revascularization for moyamoya disease: is there a benefical effect for adult patients? Surg Neurol 45:541–548PubMedCrossRefGoogle Scholar
  19. 19.
    Miyamoto S, Japan Adult Moyamoya Trial Group. (2004) Study design for a prospective randomized trial of extracranial-intracranial bypass surgery for adults with moyamoya disease and hemor-rhagic onset: the Japan Adult Moyamoya Trial Group. Neurol Med Chir (Tokyo) 44:218–219CrossRefGoogle Scholar
  20. 20.
    Houkin K, Ishikawa T, Yoshimoto T, et al (1997) Direct and indirect revascularization for moyamoya disease: surgical techniques and peri-operative complications. Clin Neurol Neurosurg 99 Suppl 2:S142–145PubMedCrossRefGoogle Scholar
  21. 21.
    Fujimura M, Kaneta T, Mugikura S, et al. (2007) Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease. Surg Neurol 67:273–282PubMedCrossRefGoogle Scholar
  22. 22.
    Kim JE, Oh CW, Kwon OK, et al. (2008) Transient hyperperfusion after superfisial temporal artery/ middle cerebral artery bypass surgery as a possible cause of postoperative transient neurological deterioration. Cerebrovasc Dis 25:580–586PubMedCrossRefGoogle Scholar
  23. 23.
    Fujimura M, Mugikura S, Kaneta T, et al. (2009) Incidence and risk factors for symptomatic cerebral hyperperfusion following superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease. Surg Neurol 71:442–447PubMedCrossRefGoogle Scholar
  24. 24.
    Fujimura M, Kaneta T, Shimizu H, et al. (2007) Symptomatic hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in a child with moyamoya disease. Childs Nerv Syst 23:1195–1198PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2010

Authors and Affiliations

  1. 1.Department of NeurosurgeryTohoku University Graduate School of MedicineAoba-kuJapan
  2. 2.Department of NeurosurgeryKohnan HospitalSendaiJapan

Personalised recommendations